Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors

被引:21
作者
Seitz, Patricia K. [1 ,2 ]
Bremer, Nicole M. [1 ,2 ]
McGinnis, Andrew G. [1 ,2 ]
Cunningham, Kathryn A. [1 ,2 ]
Watson, Cheryl S. [1 ,3 ]
机构
[1] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
关键词
Serotonin; 5-HT2AR; 5-HT2CR; Intracellular calcium; pERK; Cell signaling; PROTEIN-COUPLED RECEPTORS; PITUITARY-TUMOR CELLS; RAPID DESENSITIZATION; CONSTITUTIVE ACTIVITY; EFFECTOR PATHWAY; 2C RECEPTORS; AGONIST; MEMBRANE; ALPHA; ERK;
D O I
10.1186/1471-2202-13-25
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The serotonin (5-HT) 2A and 2C receptors (5-HT2AR and 5-HT2CR) are involved in a wide range of physiological and behavioral processes in the mammalian central and peripheral nervous systems. These receptors share a high degree of homology, have overlapping pharmacological profiles, and utilize many of the same and richly diverse second messenger signaling systems. We have developed quantitative assays for cells stably expressing these two receptors involving minimal cell sample manipulations that dramatically improve parallel assessments of two signaling responses: intracellular calcium (Ca-i(++)) changes and activation (phosphorylation) of downstream kinases. Such profiles are needed to begin to understand the simultaneous contributions from the multiplicity of signaling cascades likely to be initiated by serotonergic ligands. Results: We optimized the Ca-i(++) assay for stable cell lines expressing either 5-HT2AR or 5-HT2CR (including dye use and measurement parameters; cell density and serum requirements). We adapted a quantitative 96-well plate immunoassay for pERK in the same cell lines. Similar cell density optima and time courses were observed for 5-HT2AR- and 5-HT2CR-expressing cells in generating both types of signaling. Both cell lines also require serum-free preincubation for maximal agonist responses in the pERK assay. However, 5-HT2AR-expressing cells showed significant release of Ca-i(++) in response to 5-HT stimulation even when preincubated in serum-replete medium, while the response was completely eliminated by serum in 5-HT2CR-expressing cells. Response to another serotonergic ligand (DOI) was eliminated by serum-replete preincubation in both cells lines. Conclusions: These data expand our knowledge of differences in ligand-stimulated signaling cascades between 5-HT2AR and 5-HT2CR. Our parallel assays can be applied to other cell and receptor systems for monitoring and dissecting concurrent signaling responses.
引用
收藏
页数:14
相关论文
共 74 条
[1]  
Agarwal D, 1997, J CELL PHYSIOL, V171, P61
[2]   Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors [J].
Aloyo, V. J. ;
Berg, K. A. ;
Spampinato, U. ;
Clarke, W. P. ;
Harvey, J. A. .
PHARMACOLOGY & THERAPEUTICS, 2009, 121 (02) :160-173
[3]   Differential Regulation of Dopamine Transporter Function and Location by Low Concentrations of Environmental Estrogens and 17β-Estradiol [J].
Alyea, Rebecca A. ;
Watson, Cheryl S. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (05) :778-783
[4]  
Anastasio NC, 2009, SOC NEUR 2009 M
[5]   Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex [J].
Anastasio, Noelle C. ;
Lanfranco, Maria Fe ;
Bubar, Marcy J. ;
Seitz, Patricia K. ;
Stutz, Sonja J. ;
McGinnis, Andrew G. ;
Watson, Cheryl S. ;
Cunningham, Kathryn A. .
JOURNAL OF NEUROCHEMISTRY, 2010, 113 (06) :1504-1515
[6]   Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase [J].
Belcheva, MM ;
Coscia, CJ .
NEUROSIGNALS, 2002, 11 (01) :34-44
[7]   Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors [J].
Berg, KA ;
Harvey, JA ;
Spampinato, U ;
Clarke, WP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (12) :625-630
[8]  
Berg KA, 1999, MOL PHARMACOL, V55, P863
[9]  
BERG KA, 1994, MOL PHARMACOL, V46, P477
[10]   Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Clarke, WP .
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 :104-110